Peripheral blood and urine metabolites and biological functions in post-stroke depression
- 19 April 2022
- journal article
- research article
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 37 (5) , 1557-1568
Abstract
Post-stroke depression (PSD) is the most common and severe neuropsychiatric complication after stroke. However, the molecular mechanism of PSD is still unclear. Previous studies have identified peripheral blood and urine metabolites associated with PSD using metabolomics techniques. We searched and systematically summarized metabolites that may be involved in metabolic changes in peripheral blood and urine of patients with PSD from the Metabolite Network of Depression Database (MENDA) and other biomedical databases. MetaboAnalyst5.0 software was used for pathway analysis and enrichment analysis of differential metabolites, and subgroup analyses were performed according to tissue types and metabolomics techniques. We identified 47 metabolites that were differentially expressed between patients with and without PSD. Five differential metabolites were found in both plasma and urine, including L-glutamic acid, pyroglutamic acid, palmitic acid, L-phenylalanine, and L-tyrosine. We integrated these metabolites into metabolic pathways, and six pathways were significantly altered. These pathways could be roughly divided into three modules including amino acid metabolism, nucleotide metabolism, and glucose metabolism. Among them, the most significantly altered pathway was “phenylalanine metabolism” and the pathway containing the most associated metabolites was “aminoacyl-tRNA biosynthesis”, which deserve further study to elucidate their role in the molecular mechanism of PSD. In summary, metabolic changes in peripheral blood and urine are associated with PSD, especially the disruption of “phenylalanine metabolism” and “aminoacyl-tRNA biosynthesis” pathways. This study provides clues to the metabolic characteristics of patients with PSD, which may help to elucidate the molecular pathogenesis of PSD.Keywords
All Related Versions
Funding Information
- the Natural Science Foundation Project of China (Grant no. 82002396)
- the In-hospital Cultivation Fund of the First Affiliated Hospital of Chongqing Medical University (PYJJ2021-07)
This publication has 59 references indexed in Scilit:
- Plasma levels of glutamate during stroke is associated with development of post-stroke depressionPsychoneuroendocrinology, 2014
- Identification of Pathways for Bipolar DisorderJAMA Psychiatry, 2014
- Excitotoxicity and stroke: Identifying novel targets for neuroprotectionProgress in Neurobiology, 2014
- Glutamate as a neurotransmitter in the healthy brainJournal of Neural Transmission, 2014
- Post‐stroke depression: mechanisms, translation and therapyJournal of Cellular and Molecular Medicine, 2012
- Homocysteine as a potential biochemical marker for depression in elderly stroke survivorsFood & Nutrition Research, 2012
- Glutamate level detection by magnetic resonance spectroscopy in patients with post-stroke depressionEuropean Archives of Psychiatry and Clinical Neuroscience, 2011
- QUADOMICS: An adaptation of the Quality Assessment of Diagnostic Accuracy Assessment (QUADAS) for the evaluation of the methodological quality of studies on the diagnostic accuracy of ‘-omics’-based technologiesClinical Biochemistry, 2008
- Single voxel proton magnetic resonance spectroscopy in post-stroke depressionPsychiatry Research: Neuroimaging, 2006
- A Multivariate Analysis of Red Blood Cell Membrane Transports and Plasma Levels of L-Tyrosine and L-Tryptophan in Depressed Patients before Treatment and after Clinical ImprovementNeuropsychobiology, 1990